|
CSTF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.805700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.522100E-03 |
| Normal-vs-Stage2 |
3.484400E-02 |
| Normal-vs-Stage3 |
4.198300E-03 |
| Normal-vs-Stage4 |
3.67390000000078E-05 |
| Stage1-vs-Stage2 |
7.990800E-01 |
| Stage1-vs-Stage3 |
3.696200E-01 |
| Stage1-vs-Stage4 |
1.106330E-02 |
| Stage2-vs-Stage3 |
7.096000E-01 |
| Stage2-vs-Stage4 |
1.117000E-01 |
| Stage3-vs-Stage4 |
1.479360E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.424140E-02 |
| Normal-vs-AfricanAmerican |
3.628400E-02 |
| Normal-vs-Asian |
1.127030E-01 |
| Caucasian-vs-AfricanAmerican |
7.866200E-01 |
| Caucasian-vs-Asian |
6.640800E-01 |
| AfricanAmerican-vs-Asian |
5.874200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.966600E-04 |
| Normal-vs-Female |
7.557300E-03 |
| Male-vs-Female |
2.645000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.141700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.022800E-03 |
| Normal-vs-Age(61-80Yrs) |
7.769600E-04 |
| Normal-vs-Age(81-100Yrs) |
1.205570E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.497200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.280780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.202200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.667600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.956600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.175800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.314800E-01 |
| Classical-VS-Follicular |
3.28449999997815E-06 |
| Classical-VS-Other |
2.140000E-01 |
| Classical-VS-Normal |
7.621700E-02 |
| Tall-VS-Follicular |
7.229800E-02 |
| Tall-VS-Other |
4.584000E-01 |
| Tall-VS-Normal |
2.466100E-02 |
| Follicular-VS-Other |
7.947800E-01 |
| Follicular-VS-Normal |
1.9919999999507E-06 |
| Other-VS-Normal |
4.106400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.016030E-03 |
| Normal-vs-N1 |
1.378060E-03 |
| N0-vs-N1 |
2.673000E-01 |
|
|
